I want to thank the many people who responded to last week’s posting** on talking publicly about being diabetic (lots of emails). It is heartening to know that most of you are quite open about your diabetes, at least in your personal lives. (Although I need to keep my eyes peeled in public restrooms –- our No.1 refuge, it seems.)
A number of people were skeptical about “talking” at work, and suggested a “need-to-know” policy…
What I hear is that the pharma industry (and Wall Street) is holding its breath for Amylin’s next big thing: Exenatide (produced in partnership with Eli Lilly & Co.). This is another injectable product (derived from lizard saliva, of all things!) that, if approved by the FDA in a few months, will be offered in a pen delivery system. This one’s mainly for Type 2 diabetics, and clinical studies have shown “marked reductions in blood…
Read more »
The FDA approval of Symlin is making big headlines, and last week I had a bunch of relatives contact me, as they tend to do, when something new and “hot” appears on the diabetes scene. The drug is targeted toward Type 1 diabetics who don’t achieve good BG control despite insulin treatments. It was apparently 18 years in the making, and is the first new drug to be marketed to Type 1 diabetics since insulin…
Read more »
Set your Tivo, guys! It’s almost here. Have you heard? The first network TV series by, about, and for diabetics, called dLife TV premieres this Sunday on CNBC, 4:00 pm PT/ 7:00 pm ET. From what I’ve seen, it appears to be a cross between “The View” and a cable-like health show featuring segments on exercise and healthy cooking. Of the four hosts, two have Type 1 diabetes and two have Type 2.
This is…
Set your Tivo, guys! It’s almost here. Have you heard? The first network TV series by, about, and for diabetics, called dLife TV premieres this Sunday on CNBC, 4:00 pm PT/ 7:00 pm ET. From what I’ve seen, it appears to be a cross between “The View” and a cable-like health show featuring segments on exercise and healthy cooking. Of the four hosts, two have Type 1 diabetes and two have Type 2.
This is…